Nursing care plan chronic obstructive pulmonary disease

CHRONIC OBSTRUCTIVE PULMONARY
DISEASE (COPD) AND ASTHMA

I. Pathophysiology

a. Chronic obstructive pulmonary disease (COPD): chronic
obstructive bronchitis and emphysema
i. Chronic airflow limitations (CAL): caused by a mixture
of small airway disease (obstructive bonchiolitis) and
parenchymal destruction (emphysema)
ii. Airway inflammation: causes structural changes, narrowing
of lumina, and loss of elastic recoil in parenchyma
b. Asthma (also called chronic reactive airway disease)
i. Chronic inflammatory disorder—episodic exacerbations
of reversible inflammation and hyperreactivity and
variable constriction of bronchial smooth muscle,
hypersecretion of mucus, and edema

II. Spirometric Classification of Severity of COPD—2007
Global Initiative for Chronic Obstructive Lung Disease
a. Stage I (mild COPD)—mild airflow limitation (FEV1/FVC
 0.70; FEV1  to 80% predicted)
b. Stage II (moderate COPD)—worsening airflow limitation
(FEV1/FVC  0.70; 50%  to FEV1  80% predicted);
shortness of breath on exertion, and cough and sputum
production may be present
c. Stage III (severe COPD)—continued worsening of airflow
limitation (FEV1/FVC  0.70; 30%  to FEV1  50%
predicted); increasing shortness of breath, reduced exercise
capacity, fatigue, and repeated exacerbations
d. Stage IV (very severe COPD)—severe airflow limitation
(FEV1/FVC  0.70; FEV1  30% predicted or FEV1
 50% predicted plus presence of chronic respiratory
failure)

III. Etiology
a. COPD
i. Risk factors: smoking (primary irritant), air pollution,
secondhand smoke, history of childhood respiratory
infections, heredity—1-antitrypsin deficiency
ii. Acute exacerbations usually due to pulmonary infections
b. Asthma
i. Tends to be acute and intermittent or episodic
ii. Genetic and environmental: household substances (such
as dust mites, pets, cockroaches, mold), pollen, foods,
latex, emotional upheaval, air pollution, cold weather,
exercise, chemicals, medications, viral infections
IV. Statistics (American Lung Association, 2006, 2007a;
National Heart, Lung and Blood Institute [NHLBI], 2008b)
a. COPD
i. Morbidity: COPD affects more than 12 million people.
ii. Mortality: It is the fourth leading cause of death in the
United States with 122,000 deaths in 2003; women’s
deaths exceed that of men (63,000 females to 59,000
males).
iii. Cost: $37.2 billion is spent each year.
b. Asthma
i. Morbidity: Asthma is most common chronic disorder in
children, affecting 6.8 million under age 18; affects
15.4 million adults.
ii. Cost: $14.7 billion is spent each year.

Care Setting

Primarily community level; however, severe exacerbations
may necessitate emergency or inpatient hospital stay.

Related Concerns
Heart failure: chronic
Pneumonia
Psychosocial aspects of care
Ventilatory assistance (mechanical)
Surgical intervention

Nursing Priorities

1. Maintain airway patency.
2. Assist with measures to facilitate gas exchange.
3. Enhance nutritional intake.
4. Prevent complications and slow progression of condition.
5. Provide information about disease process, prognosis,
and treatment regimen.

Discharge Goals

1. Ventilation/oxygenation adequate to meet self-care needs.
2. Nutritional intake meeting caloric needs.
3. Infection treated or prevented.
4. Disease process, prognosis, and therapeutic regimen
understood.
5. Plan in place to meet needs after discharge.

This entry was posted in COPD and tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.